Welcome to the 10XBeta News & Insights hub, where we bring you the latest in HealthTech innovation, industry updates, success stories on how we're shaping the future of healthcare innovation.
News
The Risks and Opportunities of Tariffs: Q&A with Marcel Botha
Apr 25, 2025
How today’s tariffs could disrupt supply chains but also spark a new era of innovation in U.S. manufacturing in this Q&A, with Marcel Botha, CEO of 10XBeta.
News
Rethinking Emergency Innovation: Lessons from the Front Lines
Mar 28, 2025
In this Pharmaceutical Executive interview, Marcel Botha, CEO of 10XBeta, reflects on the U.S.'s fragmented response to public health crises...
News
De-risking medical device startups with a systematic approach to innovation
Mar 18, 2025
Medtech startups should align with market needs and FDA requirements from the outset...
Load More
News
The Risks and Opportunities of Tariffs: Q&A with Marcel Botha
Apr 25, 2025
How today’s tariffs could disrupt supply chains but also spark a new era of innovation in U.S. manufacturing in this Q&A, with Marcel Botha, CEO of 10XBeta.
News
Rethinking Emergency Innovation: Lessons from the Front Lines
Mar 28, 2025
In this Pharmaceutical Executive interview, Marcel Botha, CEO of 10XBeta, reflects on the U.S.'s fragmented response to public health crises...
News
De-risking medical device startups with a systematic approach to innovation
Mar 18, 2025
Medtech startups should align with market needs and FDA requirements from the outset...
News
The Risks and Opportunities of Tariffs: Q&A with Marcel Botha
Apr 25, 2025
How today’s tariffs could disrupt supply chains but also spark a new era of innovation in U.S. manufacturing in this Q&A, with Marcel Botha, CEO of 10XBeta.
News
Rethinking Emergency Innovation: Lessons from the Front Lines
Mar 28, 2025
In this Pharmaceutical Executive interview, Marcel Botha, CEO of 10XBeta, reflects on the U.S.'s fragmented response to public health crises...
News
De-risking medical device startups with a systematic approach to innovation
Mar 18, 2025
Medtech startups should align with market needs and FDA requirements from the outset...
Load More